XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 104,253 $ 120,572
Short-term investments 9,000 29,716
Accounts receivable, net 3,513 3,799
Inventory 5,783 2,413
Prepaid expenses and other current assets 8,727 8,746
Total current assets 131,276 165,246
Property and equipment, net 3,735 3,843
Other assets 2,339 1,819
Total assets 137,350 170,908
Current liabilities:    
Accounts payable 6,125 4,003
Current portion of notes payable 15,401 11,551
Current portion of revenue interest financing payable 2,511 2,211
Accrued expenses 18,721 22,859
Total current liabilities 42,758 40,624
Notes payable, net of deferred financing costs 58,072 61,423
Revenue interest financing payable, net of deferred financing costs 34,642 33,766
Contract liabilities, net 17,730 17,545
Other long-term liabilities 582 785
Total liabilities 153,784 154,143
Stockholders' equity:    
Common stock, $0.001 par value; 150,000,000 shares authorized, 54,938,349 issued and 54,931,042 outstanding at March 31, 2024 and 54,585,428 issued and 54,578,121 outstanding at December 31, 2023 55 55
Additional paid-in capital 594,106 588,656
Treasury stock at cost, 7,307 shares at March 31, 2024 and December 31, 2023
Accumulated other comprehensive loss   (20)
Accumulated deficit (610,595) (571,926)
Total stockholders' (deficit) equity (16,434) 16,765
Total liabilities and stockholders' (deficit) equity $ 137,350 $ 170,908